BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2019
View Archived Issues
Size matters in RNA-seq analyses
Read More
Anti-Siglec-15 monoclonal antibody NC-318 well tolerated and active in first-in-human study
Read More
IND approval and patent application for the first-ever liquid formulation of topiramate
Read More
Results presented from ongoing phase I/II study of IDE-196
Read More
ZGN-1345 demonstrates promise in preclinical models of NASH and HCC
Read More
Phase II data presented for ziltivekimab in hemodialysis patients
Read More
SARA as a potential new therapeutic target in human chronic kidney disease
Read More
New FFA1 agonist derived from an old scaffold shows potential for treatment of type 2 diabetes
Read More
Gut microbiota dysbiosis promotes neuroinflammation in Alzheimer's disease progression
Read More
Discovery of new potent NS4B inhibitor, JMX-0254
Read More
Rat homologue of FX-201 decreases incidence and severity of osteoarthritis-related lesions
Read More
TLN1 gene mutations linked to human nephrotic syndrome
Read More
Redox repositioning reaps benefits in TB treatment
Read More
Truncated ACE2 fusion protein targets RAS overactivity in renal diseases
Read More
Data on peripheral immune responses to selgantolimod from phase II study in HBV reported
Read More
L-FABP levels correlated with sarcopenia measures in diabetic kidney disease
Read More
Eternity Bioscience patents RORC antagonists
Read More
Bristol-Myers Squibb discloses new UFO and MERTK inhibitors
Read More
Rigel Pharmaceuticals synthesizes RIPK1 inhibitors
Read More
Enanta Pharmaceuticals describes new MAP3K5 inhibitors
Read More
Kinnate Biopharma patents CDK inhibitors
Read More
FDA approves Givlaari for acute hepatic porphyria
Read More
New phase I study evaluates bispecific PSMAxCD3 antibody CC-1 in CRPC
Read More
Arcutis begins phase II study of ARQ-154 foam for seborrheic dermatitis
Read More
Phoenix Molecular initiates first-in-human study of PMD-026 in advanced breast cancer
Read More
FDA approves phase I/II trial of Hope's adipose-derived mesenchymal stem cells for Alzheimer's
Read More